INS and fatty liver disease: Within this model, an excessive lipid intake induced hepatic steatosis, while additional carbohydrate supplementation enhanced de novo lipogenesis, increased oxidative burden, and disrupted insulin signaling, ultimately accelerating disease progression [1,24].